Ret protooncogene mutations and endocrine neoplasia-a story intertwined with neural crest differentiation

Endocrinology

Volumn 137, Issue 5, 1996, Pages 1509-1511

  Gagel, Robert F ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DROSOPHILA PROTEIN; ONCOPROTEIN; PROTEIN RET; PROTEIN TYROSINE KINASE; RET ONCOGENE PROTEIN, DROSOPHILA; RET PROTEIN, MOUSE;

ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; GENETICS; HIRSCHSPRUNG DISEASE; HUMAN; MOUSE; MUTATION; NEURAL CREST; NEUROFIBROMATOSIS; NOTE; SIPPLE SYNDROME;

ANIMALS; CELL DIFFERENTIATION; DROSOPHILA PROTEINS; HIRSCHSPRUNG DISEASE; HUMANS; MICE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2B; MUTATION; NEURAL CREST; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0030138185     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/endo.137.5.8612478     Document Type: Editorial

References (22)

1. MulliganLM, KwokJBJ, HealeyCS, ElsdonMJ, EngC, GardnerE, LoveDR, MoleSE, MooreJK, PapiL, PonderMA, TeleniusH, TunnacliffeA, PonderBAJ1993Germline Mutations of the ret proto-oncogene in multiple endocrine neoplasia type 2A (MEN 2A). Nature363:458-460
2. Donis-KelleiII, ShenshenD, ChiD, CarlsonKM, ToshimaK, LairmoreTC, HoweJR, MoleyJF, GoodfellowP, WellsJrSA1993Mutations in the ret proto-oncogene are associated with MEN 2A and FMTC Hum Mol Genet2:851-856
3. HofslraRM, LandsvaterRM, CeccheriniI, StulpRP, StelwagenT, LuoY, PasiniB, HoppenerJW, van AmstelHK, RomeoG, PonderBAJ1994A mutation in the ret proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature367:375-376
4. CarlsonKM, DouS, ChiD, ScavardaN, ToshimaK, JacksonCE, WellsJrSA, GoodfellowPJ, Donis-KellerH1994Single missense mutation in the tyrosine kinase catalytic domain of the ret protoon-cogene is associated with multiple endocrine neoplasia type2B. Proc Natl Acad Sci USA91:1579-1583
5. MulliganLM, MarshDJ, RobinsonBG, LenoirG, SchuffeneckerI, ZedeniusJ, LipsCJM, GagelRF, TakaiSI, NollWW, FinkM, RoueF, LaCroixA, ThibodeauSN, FrillingA, PonderBAJ, EngC1995Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the international ret mutation consortium, j Int Med238:343-346
6. Wohllk N, Cote GJ, Evans D, Goepfert H, Ordonez N, Gagel RF, Applicationof genetic screening information to the management ofmedullary thyroid carcinoma and multiple endocrine neoplasia. Endocrine Clinics of North America, in press
7. Romeo G, Ronchetto P, Luo Y, Barone V, Seri M, Ceccherini I, Pasini B, Bocciardi R, Lerone M, Kaariainen H, Martucciello G 1994 Point mutations affecting the tyrosine kinase domain of the ret proto-oncogene in Hirschsprung's disease. Nature 367:377-378
8. AngristM, BolkS, ThielB, PuffenbergerEG, HofstraRM, BoysCHCM, CassDT, ChakravartiA1995Mutation analysis of the ret receptor tyrosine kinase in Hirschsprung's disease. Hum Mol Genet4:821-830
9. SchuchardtA, D'AgatiV, Larsson-BlombergL, CostantiniF, PachnisV1994Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature367:380-383
10. VerdyM, WeberAM, RoyCC, MorinCL, OdetteM, BrochuP1982Hirschsprung's disease in a family with multiple endocrine neoplasia type 2. J Pediatr Gastroenterol Nutr1:603-607
11. AngristM, DolkS, ThielB, PuffenbeigerEG, HofsliaRM, BuysCHCM, CassDT, ChakravartiA, ChakravartiA1995Mutation analysis of the ret receptor tyrosine kinase in Hirschsprung's disease. Hum Mol Genet4:821-830
12. TakahashiM, RitzJ, CooperGM1985Activation of a novel human transforming gene, ret, by DMA rearrangement. Cell42:581-588
13. BongarzoneI, ButtiMG, CoronelliS, BorrelloMG, SantoroM, MondelliniP, PilottiS, FuscoA, Della PortaG, PierottiMA1994Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res54: 2979-2985
14. SantoroM, OrlomagnoF, RomanoA, BottaroDP, DathanNA, GriecoM, FuscoA, VecchioG, MatoskovaB, KrausMH, Di FiiorePP1995Activation of ret as a dominant transforming gene by germ-lintr mutations uf MEN 2A and MEN 2B. Scitrnce267:381-383
15. AsaiN, IwashitaT, MatsuyamaM, TakahashiM1995Mechanisms of activation of the ret proto-oncogene by multiple endocrine neoplasia 2i mutations. Mol Cell Biol15:1613-1619
16. XingS, SmanikPA, MazzaferriEL, JhiangSM, OglesbeeMJ, TroskoJE1996Characterization of ret oncogenic activation in MEN 2 inherited cancer syndromes. Endocrinology137:1512-1519
17. CooperGM, OkenquistS, SilvermanL1980Transforming activity of DNA of chemically transformed and normal cells. Nature284: 418-421
18. SeversNJ1994Gap junction alterations in the failing heart.Eur Heart J15:53-57
19. Goldberg GS, LauAF 1993Dynamics of connexin43 phosphorylation in pp60v-src-transformed cells.Biochem J295:735-742
20. AsamotoM, TakahashiS, ImaidaK, ShiraiT, FukushimaS1994Increased gap junctional intercellular communication capacity and connexin 43 and 26 expression in rat bladder carcinogenesis. Car-cinogenesis15:2163-2166
21. KamibayashiV, OyamadaY, MoriM, OyamadaM1995Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis16:1287-1297
22. Munari-SilemY, GuerrierA, FromagetC, RabilloudR, GrosD, RousselB1994Dilftricnlicil control of coniiexin-32 and connex in-43 expression in thyroid epithelial cells: evidence for a direct relationship between connexin-32 expression and histiotypic morphogenesis. hndocrinologv135:724-734